Literature DB >> 25427640

Letter regarding Meade et al. entitled "Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemo-radiation schedules in head and neck cancer".

John D Fenwick1, Zafar Malik, Alan E Nahum, W Philip M Mayles.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25427640     DOI： 10.1007/s13277-014-2874-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  9 in total

1.  Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.

Authors:  Jack F Fowler; Paul M Harari; Felix Leborgne; José H Leborgne
Journal:  Radiother Oncol       Date:  2003-11       Impact factor: 6.280

2.  Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.

Authors:  Shreerang A Bhide; Sarah Gulliford; Ulrike Schick; Aisha Miah; Shane Zaidi; Katie Newbold; Christopher M Nutting; Kevin J Harrington
Journal:  Radiother Oncol       Date:  2012-01-24       Impact factor: 6.280

3.  French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

Authors:  René-Jean Bensadoun; Karen Bénézery; Olivier Dassonville; Nicolas Magné; Gilles Poissonnet; Alain Ramaïoli; Claire Lemanski; Sylvain Bourdin; Jacques Tortochaux; Frédéric Peyrade; Pierre-Yves Marcy; Emmanuel Chamorey; Jacques Vallicioni; Hang Seng; Claude Alzieu; Bernard Géry; Pierre Chauvel; Maurice Schneider; José Santini; François Demard; Gilles Calais
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-10       Impact factor: 7.038

4.  Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemoradiation schedules in head and neck cancer.

Authors:  Sara Meade; Paul Sanghera; John Glaholm; Andrew Hartley
Journal:  Tumour Biol       Date:  2013-10-09

5.  Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.

Authors:  John D Fenwick; Geoff P Lawrence; Zafar Malik; Alan E Nahum; W Philip M Mayles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-01       Impact factor: 7.038

6.  Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.

Authors:  B Maciejewski; K Skladowski; B Pilecki; J M Taylor; R H Withers; L Miszczyk; A Zajusz; R Suwinski
Journal:  Radiother Oncol       Date:  1996-08       Impact factor: 6.280

7.  Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG).

Authors:  J W Denham; Q J Walker; D S Lamb; C S Hamilton; P C O'Brien; N A Spry; A Hindley; M Poulsen; M O'Brien; L Tripcony
Journal:  Radiother Oncol       Date:  1996-11       Impact factor: 6.280

8.  Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.

Authors:  Ann Marie Egloff; Ju-Whei Lee; Corey J Langer; Harry Quon; Alec Vaezi; Jennifer R Grandis; Raja R Seethala; Lin Wang; Dong M Shin; Athanassios Argiris; Donghua Yang; Ranee Mehra; John Andrew Ridge; Urjeet A Patel; Barbara A Burtness; Arlene A Forastiere
Journal:  Clin Cancer Res       Date:  2014-08-08       Impact factor: 12.531

Review 9.  A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules.

Authors:  Lidia Strigari; Piernicola Pedicini; Marco D'Andrea; Paola Pinnarò; Laura Marucci; Carolina Giordano; Marcello Benassi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-10       Impact factor: 7.038
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.